Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
It was a long time ago. I don’t remember the year. I came across a study telling me that HPV increased the risk of my cancer, multiple myeloma (MM). That was the type of information that got me reciting my mantra “I wish I knew then what I know now.”
I have never farmed but I did work in the commercial printing business and I was sexually active before I got married. So I guess that’s two reasons for an increased risk of MM.
If you’re reading this post, I’m guessing that you too, are wondering about the relationship between being sexually active and your future risk of a cancer diagnosis.
The bad news-
You don’t have to have many sexual partners in your lifetime in order to contract the human papilloma virus (HPV). Keep in mind however, that the more partners you have, the more your risk increases.
The good news-
You can decrease your risk of HPV. Or I should say that according to the research, a nutritional supplement called AHCC can “clear” the HPV virus from your system. To be clear, your system will clear the HPV virus eventually on it’s own. AHCC simply clears the virus from you system faster.
The larger issue is reducing your risk of cancer. For the record, I did not think about my health in general nor my risk of cancer specifically until I was diagnosed with cancer. So this blog is a sort of “do as I say, not as I did” post.
Whether it’s specific nutritional supplements such as AHCC or curcumin to reduce your risk of cancer, or it’s lifestyle therapies such as tobacco (none), alcohol (less), nutrition (whole food, fruits/veggies)- there are many evidence-based therapies shown to reduce your risk of cancer.
To learn more about evidence-based non-conventional, non-toxic therapies shown to reduce your risk of cancer, scroll down the page, post a question or comment and I will reply to you ASAP.
Thank you,
David Emerson
“The more sexual partners an individual has had during their lifetime the greater their risk of a cancer diagnosis, potentially due to a higher likelihood of contracting sexually transmitted infections (STIs), UK researchers have discovered…
They analysed data on more than 5700 men and women who took part in a longitudinal study on ageing in which they were asked about their number of sexual partners during their lifetime.
The results indicated that, among men, having 10 or more lifetime sexual partners increased the risk of a cancer diagnosis by 69% compared with having one or no sexual partners. In women, the risk was increased by 91%…
They also underline that, due to the nature of the study, “it is possible that the association between the number of sexual partners and cancer was a chance finding”…
The researchers therefore suggest it is “plausible” that the higher the number of lifetime sexual partners, the greater the risk of contracting STIs and, subsequently, later health complications…
“Human papillomavirus (HPV) and herpes are both common viruses that can be transmitted sexually. Herpes and HPV have many similarities, meaning some people might be unsure which one they have.
HPV and herpes can both cause genital lesions, but they can also both present without symptoms. Although similar, HPV is much more common than herpes. In fact, nearly allTrusted Sourcesexually active people will have HPV at least once in their lives. But for anyone who is sexually active, it’s possible to contract one or both of these viruses at some point…”
“Discussion-The presented bench-to-bedside research provides step-wise data to support the hypothesis that AHCC supplementation modulates host immune system, specifically via suppression of elevated IFNβ levels, to effectively clear chronic, persistent HR-HPV infections.
After observing elimination of HR-HPV in vitro in the panel of human cervical cancer cell lines, animal studies were completed that also demonstrated successful, durable elimination of HR-HPV after completing AHCC supplementation.
Finally, in two “proof of concept” pilot studies of daily AHCC supplementation successful elimination of HR-HPV was achieved that was durable response.
Both the animal and human data suggests the mechanism AHCC supplementation supports the host immune system to clear HPV infections is attributed to the modulation of the expression and signaling of IFNβ that is known to be elevated in chronic viral infections (16, 17).
“HPV can cause cancers of the: